Body Composition in Children With Spinal Muscular Atrophy Types 2 and 3 Receiving Nusinersen Treatment: A Longitudinal Cohort Study
Muscle & Nerve · 2025
DOI: 10.1002/mus.28439 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Muscle & Nerve, 2025. Verfasst von Yue Yan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Children's Hospital, Zhejiang University School of Medicine; National Clinical Research Center for Child Health, Zhejiang, C…. Hauptthemen laut MEDLINE: Oligonucleotides, Body Composition, Spinal Muscular Atrophies of Childhood. Die Arbeit nennt 13 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction/Aims Body composition was reported as a biomarker of muscle atrophy in the natural history of children with spinal muscular atrophy (SMA). We aimed to analyze longitudinal changes in the body composition of patients receiving nusinersen treatment and to investigate its correlation with functional motor assessments.
Methods
This cohort study enrolled patients with SMA types 2 and 3 receiving nusinersen treatment for 14 months. Data including fat‐free mass (FFM), muscle mass (MM) and their indexes, and Hammersmith Functional Motor Scale Expanded (HFMSE) scores at baseline and at 6, 10, and 14 months were analyzed.
Results
Forty‐six patients with SMA type 2 and 3, median age at initial treatment 7.1(4.6–10.4) years, were included, with 25 males and 21 females. Compared with the baseline, FFM, MM, and indexes of both significantly increased during 14 months ( p < 0.05) while body fat mass index showed no significant change ( p = 0.18). Significant increases were noted in HFMSE scores ( p < 0.001), which were moderately correlated with FFM index and MM index. The associations between HFMSE and muscle‐related variables were strong in children who achieved walking at baseline.
Discussion
Body composition changes in muscle‐related variables were found in children with SMA types 2 and 3 who received nusinersen treatment. Higher muscle mass was associated with better motor function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Children's Hospital, Zhejiang University School of Medicine; National Clinical Research Center for Child Health, Zhejiang, China.
- Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
- Department of Clinical Nutrition, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Zhejiang, China.
ORCID-Profile: Shanshan Mao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yan, Y., Zou, X., Zhou, D., Zhu, D., Feng, Y., Yu, Y., Jin, J., Long, Q., Chen, Y., Chen, F., Gao, F., & Mao, S. (2025). Body Composition in Children With Spinal Muscular Atrophy Types 2 and 3 Receiving Nusinersen Treatment: A Longitudinal Cohort Study. Muscle & Nerve. https://doi.org/10.1002/mus.28439
Vancouver
Yan Y, Zou X, Zhou D, Zhu D, Feng Y, Yu Y, et al. Body Composition in Children With Spinal Muscular Atrophy Types 2 and 3 Receiving Nusinersen Treatment: A Longitudinal Cohort Study. Muscle & Nerve. 2025. doi:10.1002/mus.28439
BibTeX
@article{Yan2025,
author = {Yan, Yue and Zou, Xinli and Zhou, Dongming and Zhu, Danhui and Feng, Yijie and Yu, Yicheng and Jin, Jianing and Long, Qi and Chen, Yuzhi and Chen, Fei and Gao, Feng and Mao, Shanshan},
title = {Body Composition in Children With Spinal Muscular Atrophy Types 2 and 3 Receiving Nusinersen Treatment: A Longitudinal Cohort Study},
journal = {Muscle & Nerve},
year = {2025},
doi = {10.1002/mus.28439}
}
EUVIMED